XML 76 R44.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Stock Option Activity

A summary of stock option activity is set forth below (in thousands, except share and per share data):

 

 

 

 

 

 

 

Outstanding Awards

 

 

 

 

 

 

 

 

 

 

 

Number of

Shares

Available

for Grant

 

 

Number of

Shares

Underlying

Outstanding

Options

 

 

Weighted

Average

Exercise

Price

 

 

Weighted

Average

Remaining

Contractual

Term (in years)

 

 

Aggregate

Intrinsic

Value

 

Outstanding, January 1, 2018

 

 

38,055

 

 

 

963,435

 

 

$

2.02

 

 

 

9.27

 

 

$

4,977

 

Options authorized

 

 

837,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options granted

 

 

(210,452

)

 

 

210,452

 

 

$

2.26

 

 

 

 

 

 

 

 

 

Options exercised

 

 

 

 

 

(123,949

)

 

$

1.92

 

 

 

 

 

 

 

 

 

Options forfeited or cancelled

 

 

153,399

 

 

 

(153,399

)

 

$

2.25

 

 

 

 

 

 

 

 

 

Outstanding, December 31, 2018

 

 

818,002

 

 

 

896,539

 

 

$

2.04

 

 

 

8.57

 

 

$

2,436

 

Options authorized

 

 

814,184

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options granted

 

 

(1,124,430

)

 

 

1,124,430

 

 

$

5.39

 

 

 

 

 

 

 

 

 

Options exercised

 

 

 

 

 

(14,791

)

 

$

(2.12

)

 

 

 

 

 

 

 

 

Options forfeited or cancelled

 

 

145,380

 

 

 

(145,532

)

 

$

2.17

 

 

 

 

 

 

 

 

 

Outstanding, December 31, 2019

 

 

653,136

 

 

 

1,860,646

 

 

$

4.05

 

 

 

8.53

 

 

$

5,812

 

Assumed as part of the Merger

 

 

2,707,144

 

 

 

81,370

 

 

$

8.39

 

 

 

 

 

 

 

 

 

Options granted

 

 

(1,914,142

)

 

 

2,276,645

 

 

$

15.14

 

 

 

 

 

 

 

 

 

Options exercised

 

 

 

 

 

 

(210,752

)

 

$

2.18

 

 

 

 

 

 

 

 

 

Options forfeited or cancelled

 

 

293,483

 

 

 

(300,964

)

 

$

6.04

 

 

 

 

 

 

 

 

 

Outstanding, December 31, 2020

 

 

1,739,621

 

 

 

3,706,945

 

 

$

10.90

 

 

 

7.98

 

 

$

15,126

 

Shares exercisable December 31, 2020

 

 

 

 

 

 

1,219,904

 

 

$

4.64

 

 

 

5.11

 

 

$

11,563

 

Vested and expected to vest, December 31, 2020

 

 

 

 

 

 

3,706,945

 

 

$

10.90

 

 

 

7.98

 

 

$

15,126

 

Summary of Restricted Stock Activity

Activity with respect to restricted stock was as follows:

 

 

 

Number of

Shares

Underlying

Outstanding

Restricted

Stock

 

 

Weighted

Average

Grant Date

Fair Value

 

Unvested, January 1, 2018

 

 

165,699

 

 

$

4.19

 

Vested

 

 

(134,516

)

 

$

4.19

 

Unvested, December 31, 2018

 

 

31,183

 

 

$

4.19

 

Vested

 

 

(31,183

)

 

$

4.19

 

Unvested, December 31, 2019

 

 

 

 

$

 

 

 

 

 

 

 

 

 

 

Summary of Stock-Based Compensation Expense

Total stock-based compensation expense recognized was as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2020

 

 

2019

 

 

2018

 

Research and development

 

$

1,674

 

 

$

274

 

 

$

285

 

General and administrative

 

 

3,589

 

 

 

901

 

 

 

2,194

 

Total stock-based compensation

 

$

5,263

 

 

$

1,175

 

 

$

2,479

 

Schedule of Assumptions to Estimate Fair Value of Stock Options Using Black-Scholes Option Pricing Model

The Company estimated the fair value of stock options using the Black Scholes option-pricing model. The fair value of stock options is being amortized on a straight-line basis over the requisite service period of the awards. The fair value of stock options was estimated using the following weighted-average assumptions:

 

 

 

Year Ended December 31,

 

 

 

2020

 

 

2019

 

 

2018

 

Expected volatility

 

72.6%-96.3%

 

 

71.5%-86.5%

 

 

73.3%-74%

 

Risk-free interest rate

 

0.1%-1.7%

 

 

1.6%-2.5%

 

 

2.7%-2.8%

 

Dividend yield

 

0%

 

 

0%

 

 

0%

 

Expected term

 

1.00-6.08 years

 

 

5.15-6.08 years

 

 

6.02-6.08 years